FDLI Advertising and Promotion Conference: Risk Information in Direct-to-Consumer Broadcast Advertisements for Prescription Drugs
Renaissance Downtown Hotel
999 Ninth St NW, Washington, DC 20001
Amy Dow, Member of the Firm, presents "Implications for Potential Changes in Requirements for Risk Information in Direct-to-Consumer Broadcast Advertisements for Prescription Drugs," during a luncheon and facilitated roundtable discussion at the Food and Drug Law Institute's (FDLI) Advertising and Promotion Conference.
These facilitated, informal discussions provide an ideal way to engage with colleagues, gain new information, and share best practices on an advertising and promotion topic.
For more information, please visit FDLI.org.